RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)
|
|
|
|
|
|
|
|
|
3 Months Ended |
6 Months Ended |
12 Months Ended |
|
Jun. 24, 2026 |
Jun. 19, 2026 |
Apr. 20, 2026 |
Jan. 15, 2026 |
Apr. 09, 2025 |
Jun. 28, 2023 |
May 19, 2021 |
Jul. 31, 2017 |
Jun. 30, 2026 |
Dec. 31, 2025 |
Jun. 30, 2025 |
Mar. 31, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
Dec. 31, 2025 |
Jul. 24, 2026 |
| Related Party Transaction [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issuance of shares value |
|
|
|
|
|
|
|
|
$ 296,689
|
|
|
|
|
|
|
|
| Cash |
|
|
$ 1,800,000
|
|
|
|
|
|
2,066,770
|
$ 1,112,642
|
|
|
$ 2,066,770
|
|
$ 1,112,642
|
|
| Convertible Notes Payable |
|
|
$ 351,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Minimum [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Related Party Transaction [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share price |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 0.50
|
| Private Placement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Related Party Transaction [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sale of Stock, Number of Shares Issued in Transaction |
|
|
7,962,963
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sale of Stock, Price Per Share |
|
|
$ 0.27
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sale of Stock, Consideration Received Per Transaction |
|
|
$ 2,150,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Share-Based Payment Arrangement, Option [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Related Party Transaction [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Options vesting period |
|
|
|
|
|
3 years
|
|
|
|
|
|
|
|
|
|
|
| Options exercisable period |
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
|
| United Systems [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Related Party Transaction [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Related party transaction, amounts of transaction owed |
|
|
|
|
|
|
|
|
222,000
|
|
$ 285,000
|
|
471,000
|
$ 772,000
|
|
|
| Amounts owed |
|
|
|
|
|
|
|
|
667,000
|
1,100,000
|
|
|
667,000
|
|
1,100,000
|
|
| Director of Clinical Affair [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Related Party Transaction [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Royalty expense |
|
|
|
|
|
|
|
|
151,000
|
|
119,000
|
|
246,000
|
232,000
|
|
|
| Consulting fee payable |
|
|
|
|
|
|
|
|
25,000
|
|
39,000
|
|
50,000
|
78,000
|
|
|
| Consulting fee payable |
|
|
|
|
|
|
|
|
$ 392,000
|
289,000
|
|
|
$ 392,000
|
|
289,000
|
|
| Mr. Osser, Vice Chairman of Board [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Related Party Transaction [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Shares issued and owned |
|
|
|
|
|
|
|
|
2,844,028
|
|
|
|
2,844,028
|
|
|
|
| Shares to be issued at employment termination |
|
|
|
|
|
|
|
|
|
|
|
|
3,394,200
|
|
|
|
| Mr. Osser, Vice Chairman of Board [Member] | Share-Based Payment Arrangement, Option [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Related Party Transaction [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Options granted to purchase common stock |
|
|
|
|
|
|
2,000,000
|
|
|
|
|
|
|
|
|
|
| Options vesting period |
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
| Options exercisable period |
|
|
|
|
|
|
10 years
|
|
|
|
|
|
|
|
|
|
| Mr. Osser, Vice Chairman of Board [Member] | Employment Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Related Party Transaction [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Increase (decrease) in compensation |
|
|
|
|
|
|
|
$ (100,000)
|
|
|
|
|
|
|
|
|
| Employment agreement, base compensation |
|
|
|
|
|
|
|
200,000
|
|
|
|
|
|
|
|
|
| Payments for past due amounts |
|
$ 64,080
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Payments for catch up amount |
|
75,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Issuance of shares value |
|
50,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Employee benefit and cash compensation |
|
$ 48,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Employee benefit and cash compensation |
|
|
|
|
|
|
|
|
$ 14,000
|
|
|
|
$ 64,000
|
|
|
|
| Transfer of shares |
|
|
|
|
|
|
|
|
|
|
|
|
363,339
|
|
|
|
| Mr. Osser, Vice Chairman of Board [Member] | Consulting Agreement [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Related Party Transaction [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Increase (decrease) in compensation |
|
|
|
|
|
|
|
100,000
|
|
|
|
|
|
|
|
|
| Employment agreement, base compensation |
|
|
|
|
|
|
|
$ 200,000
|
|
|
|
|
|
|
|
|
| Employee benefit and cash compensation |
|
|
|
|
|
|
|
|
0.00
|
|
50,000
|
|
$ 50,000
|
100,000
|
|
|
| University Pain Medicine Center (STEMMEE) [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Related Party Transaction [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Related Party Transaction, Amounts of Transaction |
|
|
|
|
|
|
|
|
$ 12,000
|
|
15,000
|
|
18,000
|
21,000
|
|
|
| Jan Adriaan Arjan Haverhals [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Related Party Transaction [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Consulting fee payable |
|
|
|
|
|
|
|
|
|
$ 67,000
|
$ 67,000
|
$ 150,000
|
|
$ 216,000
|
|
|
| Consultants and professional services fees |
|
|
|
|
|
|
|
|
|
|
|
|
350,000
|
|
|
|
| Arjan J Haverhals and Director [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Related Party Transaction [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Related party transaction, amounts of transaction owed |
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
$ 89,000
|
|
| Agreed to waive |
|
|
|
|
|
|
|
|
|
|
|
|
$ 66,000
|
|
|
|
| Mr. Haverhals, Consultant and Director [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Related Party Transaction [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Resignation of employees |
|
|
|
|
|
|
|
|
|
|
|
|
895,013
|
|
|
|
| Mr. Neal Goldman, Ms. Benedetta Casamento, and Dr. Didier Demesmin [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Related Party Transaction [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Promissory notes |
|
|
|
|
$ 800,000
|
|
|
|
|
|
|
|
|
|
|
|
| Interest rate |
|
|
|
|
2.50%
|
|
|
|
|
|
|
|
|
|
|
|
| Gross proceeds from sale of equity securities |
|
|
|
|
$ 4,000,000
|
|
|
|
|
|
|
|
|
|
|
|
| Ownership percentage |
|
|
|
|
50.00%
|
|
|
|
|
|
|
|
|
|
|
|
| Share price |
|
|
|
|
$ 0.50
|
|
|
|
|
|
|
|
|
|
|
|
| Mr Neal Goldman [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Related Party Transaction [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Convertible Notes Payable |
|
|
$ 219,375
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of Warrant or Right, Number of Securities Called by Warrants or Rights |
|
|
812,501
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Ms Benedetta Casamento [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Related Party Transaction [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Convertible Notes Payable |
|
|
$ 87,750
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of Warrant or Right, Number of Securities Called by Warrants or Rights |
|
|
325,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Dr Didier Demesmin [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Related Party Transaction [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Convertible Notes Payable |
|
|
$ 43,875
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Class of Warrant or Right, Number of Securities Called by Warrants or Rights |
|
|
162,500
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Innovest SPA [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Related Party Transaction [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Interest rate |
|
|
|
|
|
|
|
|
|
|
|
|
11.31%
|
|
|
|
| Related party transaction description of transaction |
|
|
|
Pursuant to the MOU, and subject to certain conditions, BP4 agreed to enter into a lock-up agreement
pursuant to which it would not distribute or sell any of its shares of capital stock of the Company for twelve months following consummation
of a $2.5 million offering by the Company. The lock-up provides for early release if the Company’s stock price exceeds specified
thresholds for a defined period, permitting partial distributions of shares to BP4’s quotaholders. The Company paid BP4 $60,000
in respect of additional disbursements accumulated in connection with the transaction contemplated by the MOU, which payments are subject
to an aggregate cap of $100,000.
|
|
|
|
|
|
|
|
|
|
|
|
|
| Benedetta Casamento [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Related Party Transaction [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Related party transaction description of transaction |
(1) a salary at the rate of $75,000 per year as supplemental cash compensation, (2) 115.385%
of the amount per year she would receive each year she is Executive Chairman if she remained an independent director and for being the
chair and member of the committees she was chair and a member for such period (the “Director Equivalent”), in equity awards,
in lieu of the equity she had previously been receiving as compensation in respect of such Board and committee service, and otherwise
with the same vesting and other terms as awards of equity to directors for such Board and committee service, and (3) a one-time grant
of $100,000 of shares of restricted common stock of the Company vesting on July 1, 2026. For the current year, the amount referred to
in clause (1) above shall be $75,000, based on the Director Equivalent of $65,000.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|